Amazon now selling more Kindle books than printed books

By Geoff Duncan Published May 19, 2011

Amazon Kindle (Special Offers) — Image used with permission by copyright holder

Four years after introducing its Kindle ereader, Amazon is crowing the platform’s success with another milestone: customers are now buying more titles for the Kindle than hardback and paperback books combined. Amazon says it sold 105 Kindle books for every 100 print books in any format since April 1, including print books for which no electronic version is available. Overall, Amazon says the success of the Kindle have resulted in the fasted year-on-year growth rate for Amazon’s U.S. books business in over 10 years.

“We had high hopes that this would happen eventually, but we never imagined it would happen this quickly—we’ve been selling print books for 15 years and Kindle books for less than four years,” said Amazon.com founder and CEO Jeff Bezos, in a statement. “We’re grateful to our customers for continuing to make Kindle the bestselling e-reader in the world and the Kindle Store the most popular e-bookstore in the world.”

Recommended Videos

Amazon still isn’t saying exactly how many Kindles or Kindle books it sells, but it does claim to have sold three times as many kindle books so far in 2011 as it did during the same period a year ago. The company is emphasizing that its new Kindle with Special Offers version of the device—priced at $114—has become the best-selling member of the Kindle device family in just five weeks of availability. Amazon also noted its UK bookstore is on pace to be selling more Kindle titles than printed titles soon: since April 1, Amazon’s UK customers have been buying more than two Kindle books for every single hardback book sold.

Former Contributor

Geoff Duncan writes, programs, edits, plays music, and delights in making software misbehave. He's probably the only member…

Topics

Computing

Students who use AI every day may be falling behind, while moderate users pull ahead

New global testing data suggests more AI in the classroom isn't automatically better.

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey.

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Emerging Tech

XPENG just put its humanoid robot on the production line, and it walked itself out

IRON clocks in for its first shift

XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Emerging Tech

An AI-designed drug might help slow aging, but we’re not there yet

The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.

medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.